A
JANX icon

AlphaQuest’s Janux Therapeutics JANX Stock Holding History

AlphaQuest’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,855
Closed -$177K – 1020
2025
Q4 		$177K Buy
12,855
+5,535
+76% +$130K 0.01% 1511
2025
Q3 		$179K Sell
7,320
-2,378
-25% -$57.9K 0.01% 1465
2025
Q2 		$224K Buy
9,698
+9,440
+3,659% +$249K 0.02% 1055
2025
Q1 		$6.97K Buy
258
+140
+119% +$5.28K ﹤0.01% 1831
2024
Q4 		$6.32K Sell
118
-3,420
-97% -$181K ﹤0.01% 1553
2024
Q3 		$161K Sell
3,538
-2,257
-39% -$98.2K 0.01% 1153
2024
Q2 		$243K Buy
5,795
+4,372
+307% +$205K 0.03% 689
2024
Q1 		$53.6K Buy
+1,423
New +$31K 0.01% 924

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return